January 2007 - Volume 49 - Issue 1 - Contributor Index

Alphabetical Search
B
E
I
N
Q
U
X

The Antioxidative Effects of Long-Term Treatment Are More Pronounced for Carvedilol Than for Atenolol in Post-myocardial Infarction Patients

Jonsson, Gisli; Abdelnoor, Michael; Seljeflot, Ingebjorg; More

Journal of Cardiovascular Pharmacology. 49(1):27-32, January 2007.

The Antioxidative Effects of Long-Term Treatment Are More Pronounced for Carvedilol Than for Atenolol in Post-myocardial Infarction Patients

Jonsson, Gisli; Abdelnoor, Michael; Seljeflot, Ingebjorg; More

Journal of Cardiovascular Pharmacology. 49(1):27-32, January 2007.

Author:
Chua, Sarah MD

In High-Risk Patients, Combination of Antiinflammatory Procedures During Cardiopulmonary Bypass Can Reduce Incidences of Inflammation and Oxidative Stress

Goudeau, Jean-Jacques; Clermont, Gaëlle; Guillery, Olivier; More

Journal of Cardiovascular Pharmacology. 49(1):39-45, January 2007.

Angiotensin II Type 1 Receptor Blockade Improves Hyperglycemia-Induced Endothelial Dysfunction and Reduces Proinflammatory Cytokine Release From Leukocytes

Willemsen, Judith M; Westerink, Jan W; Dallinga-Thie, Geesje M; More

Journal of Cardiovascular Pharmacology. 49(1):6-12, January 2007.

Author:
Davis, Gillian

Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension

Sitbon, Olivier; Manes, Alessandra; Jais, Xavier; More

Journal of Cardiovascular Pharmacology. 49(1):1-5, January 2007.

Angiotensin II Type 1 Receptor Blockade Improves Hyperglycemia-Induced Endothelial Dysfunction and Reduces Proinflammatory Cytokine Release From Leukocytes

Willemsen, Judith M; Westerink, Jan W; Dallinga-Thie, Geesje M; More

Journal of Cardiovascular Pharmacology. 49(1):6-12, January 2007.

Angiotensin II Type 1 Receptor Blockade Improves Hyperglycemia-Induced Endothelial Dysfunction and Reduces Proinflammatory Cytokine Release From Leukocytes

Willemsen, Judith M; Westerink, Jan W; Dallinga-Thie, Geesje M; More

Journal of Cardiovascular Pharmacology. 49(1):6-12, January 2007.

Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension

Sitbon, Olivier; Manes, Alessandra; Jais, Xavier; More

Journal of Cardiovascular Pharmacology. 49(1):1-5, January 2007.

In High-Risk Patients, Combination of Antiinflammatory Procedures During Cardiopulmonary Bypass Can Reduce Incidences of Inflammation and Oxidative Stress

Goudeau, Jean-Jacques; Clermont, Gaëlle; Guillery, Olivier; More

Journal of Cardiovascular Pharmacology. 49(1):39-45, January 2007.

In High-Risk Patients, Combination of Antiinflammatory Procedures During Cardiopulmonary Bypass Can Reduce Incidences of Inflammation and Oxidative Stress

Goudeau, Jean-Jacques; Clermont, Gaëlle; Guillery, Olivier; More

Journal of Cardiovascular Pharmacology. 49(1):39-45, January 2007.

In High-Risk Patients, Combination of Antiinflammatory Procedures During Cardiopulmonary Bypass Can Reduce Incidences of Inflammation and Oxidative Stress

Goudeau, Jean-Jacques; Clermont, Gaëlle; Guillery, Olivier; More

Journal of Cardiovascular Pharmacology. 49(1):39-45, January 2007.

In High-Risk Patients, Combination of Antiinflammatory Procedures During Cardiopulmonary Bypass Can Reduce Incidences of Inflammation and Oxidative Stress

Goudeau, Jean-Jacques; Clermont, Gaëlle; Guillery, Olivier; More

Journal of Cardiovascular Pharmacology. 49(1):39-45, January 2007.

The Antioxidative Effects of Long-Term Treatment Are More Pronounced for Carvedilol Than for Atenolol in Post-myocardial Infarction Patients

Jonsson, Gisli; Abdelnoor, Michael; Seljeflot, Ingebjorg; More

Journal of Cardiovascular Pharmacology. 49(1):27-32, January 2007.

Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension

Sitbon, Olivier; Manes, Alessandra; Jais, Xavier; More

Journal of Cardiovascular Pharmacology. 49(1):1-5, January 2007.

Author:
Jais, Xavier MD

Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension

Sitbon, Olivier; Manes, Alessandra; Jais, Xavier; More

Journal of Cardiovascular Pharmacology. 49(1):1-5, January 2007.

Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension

Sitbon, Olivier; Manes, Alessandra; Jais, Xavier; More

Journal of Cardiovascular Pharmacology. 49(1):1-5, January 2007.

Author:
Jia, Youhong MD

The Antioxidative Effects of Long-Term Treatment Are More Pronounced for Carvedilol Than for Atenolol in Post-myocardial Infarction Patients

Jonsson, Gisli; Abdelnoor, Michael; Seljeflot, Ingebjorg; More

Journal of Cardiovascular Pharmacology. 49(1):27-32, January 2007.

The Antioxidative Effects of Long-Term Treatment Are More Pronounced for Carvedilol Than for Atenolol in Post-myocardial Infarction Patients

Jonsson, Gisli; Abdelnoor, Michael; Seljeflot, Ingebjorg; More

Journal of Cardiovascular Pharmacology. 49(1):27-32, January 2007.

Author:
Lange, Stefan A

In High-Risk Patients, Combination of Antiinflammatory Procedures During Cardiopulmonary Bypass Can Reduce Incidences of Inflammation and Oxidative Stress

Goudeau, Jean-Jacques; Clermont, Gaëlle; Guillery, Olivier; More

Journal of Cardiovascular Pharmacology. 49(1):39-45, January 2007.

Author:
Li, Li MD, PhD

Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension

Sitbon, Olivier; Manes, Alessandra; Jais, Xavier; More

Journal of Cardiovascular Pharmacology. 49(1):1-5, January 2007.

Author:
Musat, Andy MD

In High-Risk Patients, Combination of Antiinflammatory Procedures During Cardiopulmonary Bypass Can Reduce Incidences of Inflammation and Oxidative Stress

Goudeau, Jean-Jacques; Clermont, Gaëlle; Guillery, Olivier; More

Journal of Cardiovascular Pharmacology. 49(1):39-45, January 2007.

The Antioxidative Effects of Long-Term Treatment Are More Pronounced for Carvedilol Than for Atenolol in Post-myocardial Infarction Patients

Jonsson, Gisli; Abdelnoor, Michael; Seljeflot, Ingebjorg; More

Journal of Cardiovascular Pharmacology. 49(1):27-32, January 2007.

Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension

Sitbon, Olivier; Manes, Alessandra; Jais, Xavier; More

Journal of Cardiovascular Pharmacology. 49(1):1-5, January 2007.

Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension

Sitbon, Olivier; Manes, Alessandra; Jais, Xavier; More

Journal of Cardiovascular Pharmacology. 49(1):1-5, January 2007.

Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension

Sitbon, Olivier; Manes, Alessandra; Jais, Xavier; More

Journal of Cardiovascular Pharmacology. 49(1):1-5, January 2007.

Angiotensin II Type 1 Receptor Blockade Improves Hyperglycemia-Induced Endothelial Dysfunction and Reduces Proinflammatory Cytokine Release From Leukocytes

Willemsen, Judith M; Westerink, Jan W; Dallinga-Thie, Geesje M; More

Journal of Cardiovascular Pharmacology. 49(1):6-12, January 2007.

In High-Risk Patients, Combination of Antiinflammatory Procedures During Cardiopulmonary Bypass Can Reduce Incidences of Inflammation and Oxidative Stress

Goudeau, Jean-Jacques; Clermont, Gaëlle; Guillery, Olivier; More

Journal of Cardiovascular Pharmacology. 49(1):39-45, January 2007.

The Antioxidative Effects of Long-Term Treatment Are More Pronounced for Carvedilol Than for Atenolol in Post-myocardial Infarction Patients

Jonsson, Gisli; Abdelnoor, Michael; Seljeflot, Ingebjorg; More

Journal of Cardiovascular Pharmacology. 49(1):27-32, January 2007.

Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension

Sitbon, Olivier; Manes, Alessandra; Jais, Xavier; More

Journal of Cardiovascular Pharmacology. 49(1):1-5, January 2007.

Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension

Sitbon, Olivier; Manes, Alessandra; Jais, Xavier; More

Journal of Cardiovascular Pharmacology. 49(1):1-5, January 2007.

Angiotensin II Type 1 Receptor Blockade Improves Hyperglycemia-Induced Endothelial Dysfunction and Reduces Proinflammatory Cytokine Release From Leukocytes

Willemsen, Judith M; Westerink, Jan W; Dallinga-Thie, Geesje M; More

Journal of Cardiovascular Pharmacology. 49(1):6-12, January 2007.

In High-Risk Patients, Combination of Antiinflammatory Procedures During Cardiopulmonary Bypass Can Reduce Incidences of Inflammation and Oxidative Stress

Goudeau, Jean-Jacques; Clermont, Gaëlle; Guillery, Olivier; More

Journal of Cardiovascular Pharmacology. 49(1):39-45, January 2007.

In High-Risk Patients, Combination of Antiinflammatory Procedures During Cardiopulmonary Bypass Can Reduce Incidences of Inflammation and Oxidative Stress

Goudeau, Jean-Jacques; Clermont, Gaëlle; Guillery, Olivier; More

Journal of Cardiovascular Pharmacology. 49(1):39-45, January 2007.

Author:
Wang, Rong MD
Author:
Wang, Ying PhD

Angiotensin II Type 1 Receptor Blockade Improves Hyperglycemia-Induced Endothelial Dysfunction and Reduces Proinflammatory Cytokine Release From Leukocytes

Willemsen, Judith M; Westerink, Jan W; Dallinga-Thie, Geesje M; More

Journal of Cardiovascular Pharmacology. 49(1):6-12, January 2007.

The Antioxidative Effects of Long-Term Treatment Are More Pronounced for Carvedilol Than for Atenolol in Post-myocardial Infarction Patients

Jonsson, Gisli; Abdelnoor, Michael; Seljeflot, Ingebjorg; More

Journal of Cardiovascular Pharmacology. 49(1):27-32, January 2007.

Angiotensin II Type 1 Receptor Blockade Improves Hyperglycemia-Induced Endothelial Dysfunction and Reduces Proinflammatory Cytokine Release From Leukocytes

Willemsen, Judith M; Westerink, Jan W; Dallinga-Thie, Geesje M; More

Journal of Cardiovascular Pharmacology. 49(1):6-12, January 2007.

Author:
Wolf, Benita
Author:
Yip, Hon-Kan MD

Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension

Sitbon, Olivier; Manes, Alessandra; Jais, Xavier; More

Journal of Cardiovascular Pharmacology. 49(1):1-5, January 2007.

Show: